TY - JOUR T1 - Clinically Approved Nanoparticle Imaging Agents JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1833 LP - 1837 DO - 10.2967/jnumed.116.181362 VL - 57 IS - 12 AU - Avnesh S. Thakor AU - Jesse V. Jokerst AU - Pejman Ghanouni AU - Jos L. Campbell AU - Erik Mittra AU - Sanjiv S. Gambhir Y1 - 2016/12/01 UR - http://jnm.snmjournals.org/content/57/12/1833.abstract N2 - Nanoparticles are a new class of imaging agent used for both anatomic and molecular imaging. Nanoparticle-based imaging exploits the signal intensity, stability, and biodistribution behavior of submicron-diameter molecular imaging agents. This review focuses on nanoparticles used in human medical imaging, with an emphasis on radionuclide imaging and MRI. Newer nanoparticle platforms are also discussed in relation to theranostic and multimodal uses. ER -